Arymo ER medication The Medication Paper

The Medication Paper Rough Draft peer to peer

The purpose of this assignment is to draft and submit a comprehensive and complete rough draft of your medication paper in APA

format. Your rough draft should include all of the research paper elements of a final draft.
Include the following in your rough draft:

Title page
Reference page with a minimum of 5 references and appropriately used in-text citations for each
Visuals: tables, figures, graphs, charts, images, or any other non-text content. (if applicable)
Footnotes (if applicable)
Appendices (if applicable)
The paper must include the following content information:

Manufacturing company
Brand name
First in class, or not first in class
Common side effects profile
Known contradictions

Make sure you explain the special considerations that your chosen drug has on the unique populations/client groups listed below.

Special considerations should include absorption, clearance/elimination, distribution, metabolism half-life, loading dose, route of

drug administration, and steady state.

Pediatric Patients

Pediatric patients are not little adults. There are special pharmacokinetic and pharmacodynamics variations in this patient group.

Their reaction to medication can be very unpredictable. Accurate dosing is the key due to their limited body mass.

Geriatric Patients

Geriatric patients have altered pharmacokinetic and pharmacodynamics responses to medication. The process of aging and disease will

change how the body responds to drug therapy. Memory limitations and increased sensitivity to drug therapy may cause unique

problems with this population.

Patients With Renal Dysfunction

Many medications are excreted through the renal glands or metabolized and excreted renally. Dosage adjustment is the key in this

population. Many agents may cause nephrotoxicity.

Patients With Liver Dysfunction

Liver disease produces alterations in the physiology of the drugs’ pharmacokinetics in the body. Special attention should be given

to all drugs used in this client population

Obese Patients

Obese patients have alterations in their pharmacokinetic and pharmacodynamic response to medication. Many comorbidities and altered

nutritional status can be seen as responses to taking these medications. Accurate dosing is paramount.


Pregnancy and lactation can be challenging. Concerns of effects to the unborn fetus must be considered. Will treating the mother

harm the unborn fetus or nursing infant?